Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: Single- versus double-spinning approach

Knee Surgery, Sports Traumatology, Arthroscopy

Volumn 20, Issue 10, 2012, Pages 2082-2091

  Filardo, Giuseppe ^a   Kon, Elizaveta ^a   Pereira Ruiz, Maria Teresa ^b   Vaccaro, Franca ^c   Guitaldi, Rita ^b   Di Martino, Alessandro ^a   Cenacchi, Annarita ^a   Fornasari, Pier Maria ^a   Marcacci, Maurilio ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b Istituto Medicina dello Sport   (Italy)

^c FATEBENEFRATELLI HOSPITAL   (Italy)

Author keywords

Cartilage; Intra articular injection; Knee; Osteoarthritis; PRP

Indexed keywords

EID: 84865325356     PISSN: 09422056     EISSN: 14337347     Source Type: Journal    
DOI: 10.1007/s00167-011-1837-x     Document Type: Article

References (39)

1. Anitua E, Sánchez M, Nurden AT et al (2007) Platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts from arthritic patients. Rheumatology 46(12): 1769-1772.
2. Baltzer AW, Moser C, Jansen SA, Krauspe R (2009) Autologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis. Osteoarthr Cartil 17(2): 152-160.
3. Benthien JP, Schwaninger M, Behrens P (2011) We do not have evidence based methods for the treatment of cartilage defects in the knee. Knee Surg Sports Traumatol Arthrosc 19(4): 543-552.
4. Buckwalter JA, Brown TD (2004) Joint injury, repair, and remodeling: roles in post-traumatic osteoarthritis. Clin Orthop Relat Res 423: 7-16.
5. Castillo TN, Pouliot MA, Kim HJ, Dragoo JL (2011) Comparison of growth factor and platelet concentration from commercial platelet-rich plasma separation systems. Am J Sports Med 39(2): 266-271.
6. Creaney L, Hamilton B (2008) Growth factor delivery methods in the management of sports injuries: the state of play. Br J Sports Med 42(5): 314-320.
7. Curl WW, Krome J, Gordon ES, Rushing J, Smith BP, Poehling GG (1997) Cartilage injuries: a review of 31, 516 knee arthroscopies. Arthroscopy 13: 456-460.
8. Filardo G, Kon E, Buda R et al (2011) Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surg Sports Traumatol Arthrosc 19(4): 528-535.
9. Filardo G, Kon E, Della Villa S et al (2010) Use of platelet-rich plasma for the treatment of refractory jumper's knee. Int Orthop 34(6): 909-915.
10. Filardo G, Kon E, Marcacci M (2011) Reply to the letter by Dhillon and colleagues. Knee Surg Sports Traumatol Arthrosc 19(5): 865-866.
11. Filardo G, Presti ML, Kon E, Marcacci M (2010) Nonoperative biological treatment approach for partial Achilles tendon lesion. Orthopedics 33(2): 120-123.
12. Frazer A, Bunning RA, Thavarajah M, Seid JM, Russell RG (1994) Studies on type II collagen and aggrecan production in human articular chondrocytes in vitro and effects of transforming growth factor-beta and interleukin-1beta. Osteoarthr Cartil 2(4): 235-245.
13. Frisbie DD, Kawcak CE, Werpy NM, Park RD, McIlwraith CW (2007) Clinical, biochemical, and histologic effects of intra-articular administration of autologous conditioned serum in horses with experimentally induced osteoarthritis. Am J Vet Res 68: 290-296.
14. Gaissmaier C, Fritz J, Krackhardt T et al (2005) Effect of human platelet supernatant on proliferation and matrix synthesis of human articular chondrocytes in monolayer and three-dimensional alginate cultures. Biomaterials 26: 1953-1960.
15. Hochberg MC, Altman RD, Brandt KD, et al. (1995) Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee: American College of Rheumatology. Arthritis Rheum 38(11): 1541-1546.
16. Kon E, Buda R, Filardo G et al (2010) Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surg Sports Traumatol Arthrosc 18(4): 472-479.
17. Kon E, Filardo G, Delcogliano M et al (2009) Platelet-rich plasma: new clinical application: a pilot study for treatment of jumper's knee. Injury 40(6): 598-603.
18. Kon E, Filardo G, Delcogliano M, et al. (2010) Platelet autologous growth factors decrease the osteochondral regeneration capability of a collagen-hydroxyapatite scaffold in a sheep model. BMC Musculoskelet Disord 27(11): 220.
19. Kon E, Filardo G, Di Martino A, Marcacci M (2011) Platelet-rich plasma (PRP) to treat sports injuries: evidence to support its use. Knee Surg Sports Traumatol Arthrosc 19(4): 516-527.
20. Kon E, Mandelbaum B, Buda R et al (2011) Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis. Arthroscopy 27(11): 1490-1501.
21. Martin JA, Buckwalter JA (2000) The role of chondrocyte-matrix interactions in maintaining and repairing articular cartilage. Biorheology 37(1-2): 129-140.
22. Mei-Dan O, Lippi G, Sánchez M, Andia I, Maffulli N (2010) Autologous platelet-rich plasma: a revolution in soft tissue sports injury management? Phys Sportsmed 38(4): 127-135.
23. Mishra A, Tummala P, King A et al (2009) Buffered platelet-rich plasma enhances mesenchymal stem cell proliferation and chondrogenic differentiation. Tissue Eng Part C Methods 15(3): 431-435.
24. Nagata MJ, Messora MR, Furlaneto FA et al (2010) Effectiveness of two methods for preparation of autologous platelet-rich plasma: an experimental study in rabbits. Eur J Dent 4(4): 395-402.
25. O'Keefe RJ, Crabb ID, Puzas JE, Rosier RN (1994) Effects of transforming growth factor-beta 1 and fibroblast growth factor on DNA synthesis in growth plate chondrocytes are enhanced by insulin-like growth factor-I. J Orthop Res 12(3): 299-310.
26. Pujol JP, Chadjichristos C, Legendre F et al (2008) Interleukin-1 and transforming growth factor-beta 1 as crucial factors in osteoarthritic cartilage metabolism. Connect Tissue Res 49(3): 293-297.
27. Saito M, Takahashi KA, Arai Y et al (2009) Intraarticular administration of platelet-rich plasma with biodegradable gelatin hydrogel microspheres prevents osteoarthritis progression in the rabbit knee. Clin Exp Rheumatol 27: 201-207.
28. Sampson S, Reed M, Silvers H, Meng M, Mandelbaum B (2010) Injection of platelet-rich plasma in patients with primary and secondary knee osteoarthritis: a pilot study. Am J Phys Med Rehabil 89(12): 961-969.
29. Sánchez M, Anitua E, Azofra J, Aguirre JJ, Andia I (2008) Intra-articular injection of an autologous preparation rich in growth factors for the treatment of knee OA: a retrospective cohort study. Clin Exp Rheumatol 26(5): 910-913.
30. Sánchez M, Azofra J, Anitua E et al (2003) Plasma rich in growth factors to treat an articular cartilage avulsion: a case report. Med Sci Sports Exerc 35(10): 1648-1652.
31. Sanchez AR, Sheridan PJ, Kupp LI (2003) Is platelet-rich plasma the perfect enhancement factor? A current review. Int J Oral Maxillofac Implants 18: 93-103.
32. Schmidt MB, Chen EH, Lynch SE (2006) A review of the effects of insulin-like growth factor and platelet derived growth factor on in vivo cartilage healing and repair. Osteoarthr Cartil 14(5): 403-412.
33. Tschon M, Fini M, Giardino R et al (2011) Lights and shadows concerning platelet products for musculoskeletal regeneration. Front Biosci (Elite Ed) 3: 96-107.
34. Ulrich-Vinther M, Maloney MD, Schwarz EM, Rosier R, O'Keefe RJ (2003) Articular cartilage biology. J Am Acad Orthop Surg 11: 421-430.
35. Wang-Saegusa A, Cugat R, Ares O, Seijas R, Cuscó X, Garcia-Balletbó M (2011) Infiltration of plasma rich in growth factors for osteoarthritis of the knee short-term effects on function and quality of life. Arch Orthop Trauma Surg 131(3): 311-317.
36. Widuchowski W, Widuchowski J, Trzaska T (2007) Articular cartilage defects: study of 25, 124 knee arthroscopies. Knee 14: 177-182.
37. Wu W, Chen F, Liu Y, Ma Q, Mao T (2007) Autologous injectable tissue-engineered cartilage by using platelet-rich plasma: experimental study in a rabbit model. J Oral Maxillofac Surg 65: 1951-1957.
38. www.bti-implant.es/prgf-prgf.
39. Zimmermann R, Arnold D, Strasser E et al (2003) Sample preparation technique and white cell content influence the detectable levels of growth factors in platelet concentrates. Vox Sang 85(4): 283-289.